Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-023741·NextCure, Inc.
Schedule 13D ownership disclosure
NextCure Inc
Common Stock, $0.001 par value · CUSIP: 65343E207
Event date: 2025-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sofinnova Venture Partners IX, L.P. ("SVP IX")Reported CIK 0001612133
Shares: 222,654.00 · Class: 7.1%
- Sofinnova Management IX, L.L.C. ("SM IX")
Shares: 222,654.00 · Class: 7.1%
- Dr. James I. Healy ("Healy")
Shares: 222,654.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-023741
- Form type
- SCHEDULE 13D/A
- Filer
- NextCure, Inc.
- CIK
- CIK 1661059
- Filed
- Mar 05, 2026
- Reporting period
- Dec 19, 2025
- Description
- Schedule 13D beneficial ownership